Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mauna Kea Technologies
With
Cellvizio Inc.
It is a randomized controlled outcomes study including patients already treated for Barrett's Esophagus lesion(s) and undergoing high definition white light endoscopy follow up procedure, with or without pCLE guided evaluation (2 arms will be considered in this study). The procedures will be carried out per standards of practice with appropriately trained physicians.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with BE with Intestinal Metaplasia, Low Grade-IntraEpithelial Neoplasia/High Grade-IntraEpithelial Neoplasia as the original indication for ablative treatment.
Undergoing any type of endoscopic BE ablation treatment
\<2cm of circumferential BE and \<5 total islands of BE on prior to last ablation.
Age \> 18 years
Ability to provide written, informed consent
You may not be if
Participation in another clinical study
Circumferential BE
Complete eradication of BE documented by biopsies
Inability to obtain biopsies due to anticoagulation, varices, etc.
Allergy to fluorescein
Pregnancy
Renal insufficiency
Clareo Health | CLE for Assessment of Neoplasia After Mucosal Ablation or Resection of Gastrointestinal Neoplasia
